BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 12120463)

  • 1. Defense against biologic warfare with superantigen toxins.
    Kaempfer R; Arad G; Levy R; Hillman D
    Isr Med Assoc J; 2002 Jul; 4(7):520-3. PubMed ID: 12120463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superantigen antagonist blocks Th1 cytokine gene induction and lethal shock.
    Arad G; Hillman D; Levy R; Kaempfer R
    J Leukoc Biol; 2001 Jun; 69(6):921-7. PubMed ID: 11404377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
    Arad G; Levy R; Hillman D; Kaempfer R
    Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide antagonists of superantigen toxins.
    Kaempfer R
    Mol Divers; 2004; 8(2):113-20. PubMed ID: 15209162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broad-spectrum immunity against superantigens is elicited in mice protected from lethal shock by a superantigen antagonist peptide.
    Arad G; Hillman D; Levy R; Kaempfer R
    Immunol Lett; 2004 Feb; 91(2-3):141-5. PubMed ID: 15019282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality.
    Kum WW; Laupland KB; Chow AW
    Can J Microbiol; 2000 Feb; 46(2):171-9. PubMed ID: 10721486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human CD4 and human major histocompatibility complex class II (DQ6) transgenic mice: supersensitivity to superantigen-induced septic shock.
    Yeung RS; Penninger JM; Kündig T; Khoo W; Ohashi PS; Kroemer G; Mak TW
    Eur J Immunol; 1996 May; 26(5):1074-82. PubMed ID: 8647170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired resistance to superantigen-induced T cell shock. V beta selective T cell unresponsiveness unfolds directly from a transient state of hyperreactivity.
    Miethke T; Wahl C; Heeg K; Wagner H
    J Immunol; 1993 May; 150(9):3776-84. PubMed ID: 8473732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A broad-spectrum inhibitory peptide against staphylococcal enterotoxin superantigen SEA, SEB and SEC.
    Wang S; Li Y; Xiong H; Cao J
    Immunol Lett; 2008 Dec; 121(2):167-72. PubMed ID: 19028523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1.
    Kum WW; Chow AW
    J Infect Dis; 2001 Jun; 183(12):1739-48. PubMed ID: 11372026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Superantigens and antigen recognition of T lymphocytes].
    Gülmezoğlu E
    Mikrobiyol Bul; 1993 Apr; 27(2):164-70. PubMed ID: 8502189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses.
    Bohach GA; Fast DJ; Nelson RD; Schlievert PM
    Crit Rev Microbiol; 1990; 17(4):251-72. PubMed ID: 2206394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1.
    Miethke T; Duschek K; Wahl C; Heeg K; Wagner H
    Eur J Immunol; 1993 Jul; 23(7):1494-500. PubMed ID: 8325325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the role of HLA-DQ polymorphisms on immune response to bacterial superantigens using transgenic mice.
    Rajagopalan G; Polich G; Sen MM; Singh M; Epstein BE; Lytle AK; Rouse MS; Patel R; David CS
    Tissue Antigens; 2008 Feb; 71(2):135-45. PubMed ID: 18086265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bacterial superantigen and superantigen-like proteins.
    Fraser JD; Proft T
    Immunol Rev; 2008 Oct; 225():226-43. PubMed ID: 18837785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lethal shock induced by streptococcal pyrogenic exotoxin A in mice transgenic for human leukocyte antigen-DQ8 and human CD4 receptors: implications for development of vaccines and therapeutics.
    Welcher BC; Carra JH; DaSilva L; Hanson J; David CS; Aman MJ; Bavari S
    J Infect Dis; 2002 Aug; 186(4):501-10. PubMed ID: 12195377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of total body irradiation and cyclosporin a on the lethality of toxic shock syndrome toxin-1 in a rabbit model of toxic shock syndrome.
    Dinges MM; Gregerson DS; Tripp TJ; McCormick JK; Schlievert PM
    J Infect Dis; 2003 Oct; 188(8):1142-5. PubMed ID: 14551884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcal enterotoxin B induces hepatic injury and lethal shock in endotoxin-resistant C3H/HeJ mice despite a deficient macrophage response.
    Yasuda S; Nagaki M; Moriwaki H
    J Endotoxin Res; 2002; 8(4):253-61. PubMed ID: 12230915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and molecular mechanisms of immune activation by microbial superantigens: studies using toxic shock syndrome toxin-1.
    Chatila T; Scholl P; Ramesh N; Trede N; Fuleihan R; Morio T; Geha RS
    Chem Immunol; 1992; 55():146-71. PubMed ID: 1418616
    [No Abstract]   [Full Text] [Related]  

  • 20. Separation of function between the domains of toxic shock syndrome toxin-1.
    Wahlsten JL; Ramakrishnan S
    J Immunol; 1998 Jan; 160(2):854-9. PubMed ID: 9551921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.